Mouse Anti-LAP2 Antibody (CBMOAB-02040CR)
Cat: CBMOAB-02040CR
Certificate of Analysis Lookup
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number
- Product List
- Specifications
- Application Information
- Target
| Sub Cat | Clonality | Species Reactivity | Application | Clone | Conjugate | Size | |
| CBMOAB-02040CR | Monoclonal | Yeast, C. elegans (Caenorhabditis elegans), Frog (Xenopus laevis) | WB, ELISA | MO02040CR | 100 µg | ||
| CBMOAB-05767HCB | Monoclonal | C. elegans (Caenorhabditis elegans) | WB, ELISA | MO05767HB | 100 µg | ||
| MO-AB-04779H | Monoclonal | Frog (Xenopus laevis) | WB, ELISA | MO04779C | 100 µg |
Specifications
| Host species | Mouse (Mus musculus) |
| Species Reactivity | Yeast, C. elegans (Caenorhabditis elegans), Frog (Xenopus laevis) |
| Clone | MO02040CR |
| Specificity | This antibody binds to Yeast LAP2. |
| Format | Liquid or Lyophilized |
| Storage | Store at 4°C: short-term (1-2weeks) Store at -20°C: long-term and future use |
| Purity | > 90% was determined by SDS-PAGE |
| Purification | Purified with Protein A or G affinity chromatography |
| Cellular Localization | Nucleus; Other locations |
Application Information
| Application | WB, ELISA |
| Application Notes | ELISA: 1:1000-1:3000 Other applications are to be developed. The optimal dilution should be determined by the end user. |
Target
| Product Overview | Mouse Anti-Yeast LAP2 Antibody is a mouse antibody against LAP2. It can be used for LAP2 detection in Western Blot, Enzyme-Linked Immunosorbent Assay. |
| Alternative Names | Leukotriene A-4 hydrolase homolog; LTA-4 hydrolase; EC 3.3.2.6; Leucine aminopeptidase 2; Leukotriene A(4) hydrolase; LAP2; YNL045W |
| UniProt ID | Q10740 |
| Protein Refseq | The length of the protein is 671 amino acids long. The sequence is show below: MFLLPFVIRHSSSIYLPTLRFRGLLTVISRNIHISTPHKMLPLSIEQRRPSRSPEYDQSTLSNYKDFAVLHTDLNLSVSFEKSAISGSVTFQLKKLHEGKNKSDELHLDTSYLDVQEVHIDGSKADFQIEQRKEPLGSRLVINNASCNDNFTLNIQFRTTDKCTALQWLNSKQTKGGKPYVFSQLEAIHARSLFPCFDTPSVKSTFTASIESPLPVVFSGIRIEDTSKDTNIYRFEQKVPIPAYLIGIASGDLSSAPIGPRSTVYTEPFRLKDCQWEFENDVEKFIQTAEKIIFEYEWGTYDILVNVDSYPYGGMESPNMTFATPTLIAHDRSNIDVIAHELAHSWSGNLVTNCSWNHFWLNEGWTVYLERRIIGAIHGEPTRHFSALIGWSDLQNSIDSMKDPERFSTLVQNLNDNTDPDDAFSTVPYEKGFNLLFHLETILGGKAEFDPFIRHYFKKFAKKSLDTFQFLDTLYEFYPEKKEILDSVDWETWLYKPGMPPRPHFITALADNVYQLADKWVEMAQHLKTTEDFRSEFNAIDIKDFNSNQLVLFLETLTQNGHSNKKPKDFDWAKFPVASRALLDIYQDNIVKSQNAEVVFKMFKFQIFAKLQEEYKHLADWLGTVGRMKFVRPGYRLLNSVDRRLALATFDKFKDTYHPICKALVKQDLGL. |
For Research Use Only | Not For Clinical Use.
Online Inquiry